Role of the laboratory in diabetes diagnosis and screening-The 2013 CDA CPGs

Clinical Biochemistry

Volumn 46, Issue 9, 2013, Pages 707-709

  Punthakee, Zubin ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EDITORIAL; GESTATIONAL AGE; GLYCEMIC CONTROL; HUMAN; LABORATORY; LABORATORY DIAGNOSIS; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK ASSESSMENT;

CANADA; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC;

EID: 84877821978     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.04.019     Document Type: Editorial

References (21)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013, 37:S1-S212.
2. Bennett W.L., Odelola O.A., Wilson L.M., et al. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review. Ann Intern Med 2012, 156:27-36.
3. Goldberg R.M., Cheng A.Y.Y., Punthakee Z., Clement M. Use of glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diabetes 2011, 35:247-249.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329:977-986.
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:837-853.
6. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197.
7. Little R.R., Rohlfing C.L., Sacks D.B. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011, 57:205-214.
8. American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract 2010, 16:155-156.
9. WHO Consultation Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus 2011, WHO, [[cited 2011 Jun 14]; Available from: URL: http://www.who.int/entity/diabetes/publications/report-hba1c_2011.pdf].
10. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl. 1):S62-S69.
11. International Diabetes Federation Clinical Guidelines Taskforce Global guideline for type 2 diabetes 2012, IDF, [[cited 2013 Apr 20]; Available from: URL: http://www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf].
12. Sacks D.B. A1C versus glucose testing: a comparison. Diabetes Care 2011, 34:518-523.
13. Zhang X., Gregg E.W., Williamson D.F., et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010, 33:1665-1673.
14. Berger H., Crane J., Farine D., et al. Screening for gestational diabetes mellitus. J Obstet Gynaecol Can 2002, 24:894-912.
15. Metzger B.E., Lowe L.P., Dyer A.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002.
16. Standards of medical care in diabetes-2013. Diabetes Care 2013, 36(Suppl. 1):S11-S66.
17. Metzger B.E., Gabbe S.G., Persson B., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
18. Lavin J.P., Lavin B., O'Donnell N. A comparison of costs associated with screening for gestational diabetes with two-tiered and one-tiered testing protocols. Am J Obstet Gynecol 2001, 184:363-367.
19. Jeppsson J.O., Kobold U., Barr J., et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002, 40:78-89.
20. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400.
21. Oleschuk C.J., Prosser C., Dooley K., et al. Position statement of the Canadian Society of Clinical Chemists and Canadian Association of Medical Biochemists on hemoglobin A1c measurement and reporting. Clin Biochem 2012, 45:1036-1037.